Loading…
Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned
Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease. One in every ten cases of reflux esophagitis leads to...
Saved in:
Published in: | Diagnostics (Basel) 2023-08, Vol.13 (16), p.2664 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c494t-d7dc1125c3f9a115edc166ba2f281f5a5de5e53eb659624dec8a245716b69e343 |
container_end_page | |
container_issue | 16 |
container_start_page | 2664 |
container_title | Diagnostics (Basel) |
container_volume | 13 |
creator | Maev, Igor V Livzan, Maria A Mozgovoi, Sergei I Gaus, Olga V Bordin, Dmitry S |
description | Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease. One in every ten cases of reflux esophagitis leads to the formation of Barrett’s esophagus, which is associated with a high risk of esophagus adenocarcinoma. The key factors determining the progression of the disease are the frequency and duration of the reflux of the stomach’s contents. As a result, refluxate, which includes hydrochloric acid, pepsin, and, in the case of concomitant duodeno-gastric reflux, bile acids and lysolecithin, is thrown into the overlying sections of the digestive tract. At the same time, in addition to aggression factors, it is necessary to take into account the state of resistance in the esophageal mucosa to the effects of aggressive refluxate molecules. This review was prepared using systematized data on the protective properties of the esophageal mucosa and modern methods to assess the mucosal barrier in reflux esophagitis. Lesions of the epithelial barrier structure in the esophagus are recognized as the main pathogenetic factor in the development of reflux esophagitis and are a potentially significant therapeutic target in the treatment of GERD and Barrett’s esophagus. This article presents the characteristics of the esophageal mucosal barrier and the protective mechanisms of the esophagus’s mucous membrane in conditions of gastroesophageal reflux. Diagnostic approaches for assessing the course of reflux esophagitis are described for both histological criteria and the possibility of a comprehensive assessment of the state of mucins, tight-junction proteins, and the proliferative activity of the mucosa, including under the conditions of ongoing therapy. |
doi_str_mv | 10.3390/diagnostics13162664 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9dbf2c88b4c24da2bc4b59d6787fb9b8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A762474601</galeid><doaj_id>oai_doaj_org_article_9dbf2c88b4c24da2bc4b59d6787fb9b8</doaj_id><sourcerecordid>A762474601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-d7dc1125c3f9a115edc166ba2f281f5a5de5e53eb659624dec8a245716b69e343</originalsourceid><addsrcrecordid>eNptkk1vEzEQhlcIRKvSX8DFEhcuKevPtbmgUrW0UhBSAfVozXpnE0cbO9i7Vfn3OCSKCKp9GI_9zuMZe6rqLa0vODf1h87DIsQ8epcpp4opJV5Up6xu5EwIql_-sz6pznNe1WUYyjWTr6sT3ijWGMZPq3id42YJC4SBfJ1czMXeY_Z5hOCQ-FC8fpieyF7nR58_kocljOQByS08IpkjpIAd-R7JDSQCodud3-MafMhkjOTzQfWmetXDkPF8b8-qnzfXP65uZ_NvX-6uLuczJ4wYZ13TOUqZdLw3QKnE4irVAuuZpr0E2aFEybFV0igmOnQamJANVa0yyAU_q-523C7Cym6SX0P6bSN4-3cjpoWFVF5vQGu6tmdO61a4QgLWOtFK06lGN31rWl1Yn3aszdSuSyYYxgTDEfT4JPilXcRHS2shuaGmEN7vCSn-mjCPdu2zw2GAgHHKlmnZaMmE2ib-7j_pKk4plLfaqpTRnBboQbWAUoEPfSwXuy3UXpa_FY1QNS2qi2dUZXa49i4G7H3ZPwrguwCXYs4J-0ORtLbbvrPP9B3_AxI3yzg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2856983145</pqid></control><display><type>article</type><title>Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Maev, Igor V ; Livzan, Maria A ; Mozgovoi, Sergei I ; Gaus, Olga V ; Bordin, Dmitry S</creator><creatorcontrib>Maev, Igor V ; Livzan, Maria A ; Mozgovoi, Sergei I ; Gaus, Olga V ; Bordin, Dmitry S</creatorcontrib><description>Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease. One in every ten cases of reflux esophagitis leads to the formation of Barrett’s esophagus, which is associated with a high risk of esophagus adenocarcinoma. The key factors determining the progression of the disease are the frequency and duration of the reflux of the stomach’s contents. As a result, refluxate, which includes hydrochloric acid, pepsin, and, in the case of concomitant duodeno-gastric reflux, bile acids and lysolecithin, is thrown into the overlying sections of the digestive tract. At the same time, in addition to aggression factors, it is necessary to take into account the state of resistance in the esophageal mucosa to the effects of aggressive refluxate molecules. This review was prepared using systematized data on the protective properties of the esophageal mucosa and modern methods to assess the mucosal barrier in reflux esophagitis. Lesions of the epithelial barrier structure in the esophagus are recognized as the main pathogenetic factor in the development of reflux esophagitis and are a potentially significant therapeutic target in the treatment of GERD and Barrett’s esophagus. This article presents the characteristics of the esophageal mucosal barrier and the protective mechanisms of the esophagus’s mucous membrane in conditions of gastroesophageal reflux. Diagnostic approaches for assessing the course of reflux esophagitis are described for both histological criteria and the possibility of a comprehensive assessment of the state of mucins, tight-junction proteins, and the proliferative activity of the mucosa, including under the conditions of ongoing therapy.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics13162664</identifier><identifier>PMID: 37627923</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Bile ; Bile acids ; Coronary heart disease ; Development and progression ; Disease ; Esophageal diseases ; Esophagus ; Gastroesophageal reflux ; gastroesophageal reflux disease ; Growth factors ; Health aspects ; Hydrochloric acid ; Hypertension ; Microbiota ; Mucins ; mucosal barrier ; mucosal resistance ; Proteins ; reflux esophagitis ; Review</subject><ispartof>Diagnostics (Basel), 2023-08, Vol.13 (16), p.2664</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c494t-d7dc1125c3f9a115edc166ba2f281f5a5de5e53eb659624dec8a245716b69e343</cites><orcidid>0000-0003-2815-3992 ; 0000-0001-7200-7082 ; 0000-0001-9370-4768 ; 0000-0002-6581-7017</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2856983145/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2856983145?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Maev, Igor V</creatorcontrib><creatorcontrib>Livzan, Maria A</creatorcontrib><creatorcontrib>Mozgovoi, Sergei I</creatorcontrib><creatorcontrib>Gaus, Olga V</creatorcontrib><creatorcontrib>Bordin, Dmitry S</creatorcontrib><title>Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned</title><title>Diagnostics (Basel)</title><description>Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease. One in every ten cases of reflux esophagitis leads to the formation of Barrett’s esophagus, which is associated with a high risk of esophagus adenocarcinoma. The key factors determining the progression of the disease are the frequency and duration of the reflux of the stomach’s contents. As a result, refluxate, which includes hydrochloric acid, pepsin, and, in the case of concomitant duodeno-gastric reflux, bile acids and lysolecithin, is thrown into the overlying sections of the digestive tract. At the same time, in addition to aggression factors, it is necessary to take into account the state of resistance in the esophageal mucosa to the effects of aggressive refluxate molecules. This review was prepared using systematized data on the protective properties of the esophageal mucosa and modern methods to assess the mucosal barrier in reflux esophagitis. Lesions of the epithelial barrier structure in the esophagus are recognized as the main pathogenetic factor in the development of reflux esophagitis and are a potentially significant therapeutic target in the treatment of GERD and Barrett’s esophagus. This article presents the characteristics of the esophageal mucosal barrier and the protective mechanisms of the esophagus’s mucous membrane in conditions of gastroesophageal reflux. Diagnostic approaches for assessing the course of reflux esophagitis are described for both histological criteria and the possibility of a comprehensive assessment of the state of mucins, tight-junction proteins, and the proliferative activity of the mucosa, including under the conditions of ongoing therapy.</description><subject>Bile</subject><subject>Bile acids</subject><subject>Coronary heart disease</subject><subject>Development and progression</subject><subject>Disease</subject><subject>Esophageal diseases</subject><subject>Esophagus</subject><subject>Gastroesophageal reflux</subject><subject>gastroesophageal reflux disease</subject><subject>Growth factors</subject><subject>Health aspects</subject><subject>Hydrochloric acid</subject><subject>Hypertension</subject><subject>Microbiota</subject><subject>Mucins</subject><subject>mucosal barrier</subject><subject>mucosal resistance</subject><subject>Proteins</subject><subject>reflux esophagitis</subject><subject>Review</subject><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vEzEQhlcIRKvSX8DFEhcuKevPtbmgUrW0UhBSAfVozXpnE0cbO9i7Vfn3OCSKCKp9GI_9zuMZe6rqLa0vODf1h87DIsQ8epcpp4opJV5Up6xu5EwIql_-sz6pznNe1WUYyjWTr6sT3ijWGMZPq3id42YJC4SBfJ1czMXeY_Z5hOCQ-FC8fpieyF7nR58_kocljOQByS08IpkjpIAd-R7JDSQCodud3-MafMhkjOTzQfWmetXDkPF8b8-qnzfXP65uZ_NvX-6uLuczJ4wYZ13TOUqZdLw3QKnE4irVAuuZpr0E2aFEybFV0igmOnQamJANVa0yyAU_q-523C7Cym6SX0P6bSN4-3cjpoWFVF5vQGu6tmdO61a4QgLWOtFK06lGN31rWl1Yn3aszdSuSyYYxgTDEfT4JPilXcRHS2shuaGmEN7vCSn-mjCPdu2zw2GAgHHKlmnZaMmE2ib-7j_pKk4plLfaqpTRnBboQbWAUoEPfSwXuy3UXpa_FY1QNS2qi2dUZXa49i4G7H3ZPwrguwCXYs4J-0ORtLbbvrPP9B3_AxI3yzg</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Maev, Igor V</creator><creator>Livzan, Maria A</creator><creator>Mozgovoi, Sergei I</creator><creator>Gaus, Olga V</creator><creator>Bordin, Dmitry S</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2815-3992</orcidid><orcidid>https://orcid.org/0000-0001-7200-7082</orcidid><orcidid>https://orcid.org/0000-0001-9370-4768</orcidid><orcidid>https://orcid.org/0000-0002-6581-7017</orcidid></search><sort><creationdate>20230801</creationdate><title>Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned</title><author>Maev, Igor V ; Livzan, Maria A ; Mozgovoi, Sergei I ; Gaus, Olga V ; Bordin, Dmitry S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-d7dc1125c3f9a115edc166ba2f281f5a5de5e53eb659624dec8a245716b69e343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bile</topic><topic>Bile acids</topic><topic>Coronary heart disease</topic><topic>Development and progression</topic><topic>Disease</topic><topic>Esophageal diseases</topic><topic>Esophagus</topic><topic>Gastroesophageal reflux</topic><topic>gastroesophageal reflux disease</topic><topic>Growth factors</topic><topic>Health aspects</topic><topic>Hydrochloric acid</topic><topic>Hypertension</topic><topic>Microbiota</topic><topic>Mucins</topic><topic>mucosal barrier</topic><topic>mucosal resistance</topic><topic>Proteins</topic><topic>reflux esophagitis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maev, Igor V</creatorcontrib><creatorcontrib>Livzan, Maria A</creatorcontrib><creatorcontrib>Mozgovoi, Sergei I</creatorcontrib><creatorcontrib>Gaus, Olga V</creatorcontrib><creatorcontrib>Bordin, Dmitry S</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maev, Igor V</au><au>Livzan, Maria A</au><au>Mozgovoi, Sergei I</au><au>Gaus, Olga V</au><au>Bordin, Dmitry S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned</atitle><jtitle>Diagnostics (Basel)</jtitle><date>2023-08-01</date><risdate>2023</risdate><volume>13</volume><issue>16</issue><spage>2664</spage><pages>2664-</pages><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>Gastroesophageal reflux disease (GERD) has the highest prevalence among diseases of the digestive system and is characterized by a significant decrease in patients’ quality of life, comparable to arterial hypertension and coronary heart disease. One in every ten cases of reflux esophagitis leads to the formation of Barrett’s esophagus, which is associated with a high risk of esophagus adenocarcinoma. The key factors determining the progression of the disease are the frequency and duration of the reflux of the stomach’s contents. As a result, refluxate, which includes hydrochloric acid, pepsin, and, in the case of concomitant duodeno-gastric reflux, bile acids and lysolecithin, is thrown into the overlying sections of the digestive tract. At the same time, in addition to aggression factors, it is necessary to take into account the state of resistance in the esophageal mucosa to the effects of aggressive refluxate molecules. This review was prepared using systematized data on the protective properties of the esophageal mucosa and modern methods to assess the mucosal barrier in reflux esophagitis. Lesions of the epithelial barrier structure in the esophagus are recognized as the main pathogenetic factor in the development of reflux esophagitis and are a potentially significant therapeutic target in the treatment of GERD and Barrett’s esophagus. This article presents the characteristics of the esophageal mucosal barrier and the protective mechanisms of the esophagus’s mucous membrane in conditions of gastroesophageal reflux. Diagnostic approaches for assessing the course of reflux esophagitis are described for both histological criteria and the possibility of a comprehensive assessment of the state of mucins, tight-junction proteins, and the proliferative activity of the mucosa, including under the conditions of ongoing therapy.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37627923</pmid><doi>10.3390/diagnostics13162664</doi><orcidid>https://orcid.org/0000-0003-2815-3992</orcidid><orcidid>https://orcid.org/0000-0001-7200-7082</orcidid><orcidid>https://orcid.org/0000-0001-9370-4768</orcidid><orcidid>https://orcid.org/0000-0002-6581-7017</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2075-4418 |
ispartof | Diagnostics (Basel), 2023-08, Vol.13 (16), p.2664 |
issn | 2075-4418 2075-4418 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_9dbf2c88b4c24da2bc4b59d6787fb9b8 |
source | Publicly Available Content Database; PubMed Central |
subjects | Bile Bile acids Coronary heart disease Development and progression Disease Esophageal diseases Esophagus Gastroesophageal reflux gastroesophageal reflux disease Growth factors Health aspects Hydrochloric acid Hypertension Microbiota Mucins mucosal barrier mucosal resistance Proteins reflux esophagitis Review |
title | Esophageal Mucosal Resistance in Reflux Esophagitis: What We Have Learned So Far and What Remains to Be Learned |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T08%3A50%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Esophageal%20Mucosal%20Resistance%20in%20Reflux%20Esophagitis:%20What%20We%20Have%20Learned%20So%20Far%20and%20What%20Remains%20to%20Be%20Learned&rft.jtitle=Diagnostics%20(Basel)&rft.au=Maev,%20Igor%20V&rft.date=2023-08-01&rft.volume=13&rft.issue=16&rft.spage=2664&rft.pages=2664-&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics13162664&rft_dat=%3Cgale_doaj_%3EA762474601%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c494t-d7dc1125c3f9a115edc166ba2f281f5a5de5e53eb659624dec8a245716b69e343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2856983145&rft_id=info:pmid/37627923&rft_galeid=A762474601&rfr_iscdi=true |